Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

mRNA, easy to customise, is the next frontier for personalised medicine

Because it is so easy to change the mRNA recipes, cancer vaccines can be part of a personalized medicine plan where doctors sample a patient’s tumour, sequence key genes and adjust the mRNA treatment to include recipes specific to that patient’s cancer. Clinical trials using this personalized approach for pancreatic…

The Hindu

Get Your Shots Immediately: CDC Warns Of 'Urgent Need' To Boost Vaccine Coverage As Respiratory Illnesses Surge

Low vaccination rates against influenza, COVID-19 and RSV, along with an increase in respiratory diseases, could pose a potential strain on the healthcare system, the CDC warned.

Medical Daily

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Globally there were an estimated 325,000 new melanoma cases and 57 ,000 deaths from the disease in 2020.

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Tests Promising Personalized Skin Cancer Vaccine with 49% Improvement!

Moderna tests a novel approach to battle skin cancer, with a vaccine showing benefits for melanoma patients. Treatment could be available by 2025.

Top News

Moderna CEO Says Melanoma Vaccine Could Be Available By 2025

Moderna CEO Stephane Bancel told AFP his company's experimental vaccine against melanoma could be available in as little as two years, in what would amount to a landmark step against the most serious form of skin cancer.

International Business Times

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which diseases to pursue developing drugs for?

The Conversation

Special vaccination camp launched for children

Health Dept launches special camp in Chennai to provide Measles-Rubella vaccine to 27.42 lakh children aged 9 months-15 years in cyclone-hit districts. 10 lakh doses sought from Union govt. 6,421 camps organised, 4.69 lakh persons benefited, 6,403 with fever, 71,561 with cough/cold.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Health misinformation is rampant on social media – here's what it does, why it spreads and what people can do about it

The global anti-vaccine movement and vaccine hesitancy that accelerated during the COVID-19 pandemic show no signs of abating.

The Conversation

COVID-19 pandemic response continues to press on budget

Continuing to pay for COVID-19 vaccines and treatments will cost Australians hundreds of millions of dollars, with the threat posed by the virus far from over.

AAP

There’s more work to do to close the racial gap in COVID-19, flu vaccination

The Urban League and other groups worked hard during the pandemic to raise vaccination rates among Black Americans. The gap is smaller, but Blacks are still less likely than whites to receive COVID-19 and influenza vaccines.

Chicago Sun-Times

AstraZeneca buys US vaccine company in $1.1bn deal

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

The Guardian - UK

UKHSA Highlights Disparities in Flu and COVID-19 Hospital Admissions

UK Health Security Agency (UKHSA) has issued a strong call to action, urging eligible individuals, especially those from ethnic minority groups, to book their flu and COVID-19 vaccines.

International Business Times UK

Africa Trials for HIV Vaccine Discontinued as Initial Results Disappoint

The African-led trial was initiated in December 2020 but came to an early halt last month. Its conclusive findings are to be released in 2024.

International Business Times UK

Whooping cough cases increasing in the UK – what you need to know

You may have read recent alarming reports of a cough that “lasts 100 days” is “quickly spreading across the UK” and can “fracture ribs”. If you didn’t look beyond the headlines, you might have missed the fact that the reports are about whooping cough.

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

New COVID-19 vaccines hit pharmacy shelves

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

The Hindu

Over 1.32 lakh persons screened at camps in Tamil Nadu

Special medical camps held in cyclone-affected districts of TN screen 1.3L; MR vaccine advised for children in flood-hit areas. Health Minister launched camps in 679 places, 200 each in Tiruvallur & Chengalpattu, 100 in Kancheepuram. Screening for dengue, chikungunya, diarrhoea, sore throat & cough; MR vaccine advised for children in…

LiveScience

Rare clotting effect of early COVID shots finally explained — what could that mean for future vaccines?

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.

The Guardian - UK

What is whooping cough and why are cases rising in England and Wales?

Data shows increase in infections and experts advise vaccination for pregnant women, babies and young children

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Improved drug regimens for TB to cut treatment time

At The Union World Conference on Lung Health, optimism abounded as new drug regimens were presented that could cut treatment time for drug-resistant TB by up to two-thirds. These regimens, with 85-90% success rates, offer hope to those affected by MDR-TB, who often face long treatments and 14,000 pills. Funding…

The Guardian - UK

HIV vaccine trial in Africa halted after disappointing initial results

African-led trial ended a year early as researchers conclude there is ‘little or no chance’ new combination vaccines cut HIV risk

LiveScience

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

Salon

COVID hospitalizations continue to rise

The highly-mutated Pirola variant is now driving a significant number of infections, but vaccine uptake is lagging

The Hindu

Giant rabies study with 50,000 dogs says only vaccines can stop disease

Katie Hampson's 15-year study of rabies in Tanzania reveals individual dog behaviour plays a key role in its endemic nature. Through contact tracing, brain samples, and modelling, researchers found that rabies spreads locally, with few "super-spreader" dogs, and that vaccination is the only effective way to prevent it. Culling was…

The Guardian - UK

Boris Johnson considered ‘raid’ on vaccine plant in the Netherlands

Covid inquiry expected to be told that the former PM was open to ‘military options’ to obtain ‘impounded’ jabs from factory in Leiden

The Hindu

Did vaccination reduce COVID-related preterm births?

COVID-19 in pregnant women in California linked to preterm births; vaccine rollout reduced risk. Study found 1.2% increase in preterm births in COVID-positive mothers, equivalent to 20 days of in utero exposure to wildfire smoke. Vaccine acceptance in areas reduced preterm birth risk, which vanished with population immunity. Mixed results…

1 … 109 110 111 112

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Centers for Disease Control and Prevention

224 stories

Conference

214 stories

The National Institutes of Health

Health Security Agency

27 stories

the National Urban League

15 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.